China Biologic Products, Inc. 4

Accession 0001144204-15-069866

CIK 0001369868operating

View on SEC.gov Company Profile

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 4:35 PM ET

Size

21.1 KB

Accession

0001144204-15-069866

Insider Transaction Report

Form 4

Period: 2015-12-04

China Biologic Products, Inc.CBPO

Tong Zhijun

Director

Transactions

Sale
Common stock
2015-12-04$119.00/sh−486$57,834→ 14,000 total
Exercise/Conversion
Common stock
2015-12-04$9.61/sh+10,000$96,100→ 24,000 total
Exercise/Conversion
Stock Option (right to buy)
2015-12-07−4,514→ 10,000 total
Exercise: $9.85From: 2013-09-01Exp: 2022-08-31→ Common stock (4,514 underlying)
Exercise/Conversion
Common stock
2015-12-04$9.85/sh+486$4,787→ 14,486 total
Sale
Common stock
2015-12-04$118.00/sh−10,000$1,180,000→ 14,000 total
Exercise/Conversion
Stock Option (right to buy)
2015-12-04−486→ 24,514 total
Exercise: $9.85From: 2013-09-01Exp: 2022-08-31→ Common stock (486 underlying)
Exercise/Conversion
Common stock
2015-12-07$9.85/sh+4,514$44,463→ 18,514 total
Sale
Common stock
2015-12-07$119.00/sh−4,514$537,166→ 14,000 total
Exercise/Conversion
Stock Option (right to buy)
2015-12-04−10,000→ 14,514 total
Exercise: $9.61From: 2012-10-21Exp: 2022-04-20→ Common stock (10,000 underlying)

Footnotes (6)

[F1]Represents 486 shares of common stock sold on the open market for $119.00 per share on December 4, 2015. These shares of common stock were acquired by the Reporting Person through the cashless exercise of stock options to purchase the Issuer's common stock. See Footnote 4 below for further details on the relevant stock options.
[F2]Represents 10,000 shares of common stock sold on the open market for $118.00 per share on December 4, 2015. These shares of common stock were acquired by the Reporting Person through the cashless exercise of stock options to purchase the Issuer's common stock. See Footnote 5 below for further details on the relevant stock options.
[F3]Represents 4,514 shares of common stock sold on the open market for $119.00 per share on December 7, 2015. These shares of common stock were acquired by the Reporting Person through the cashless exercise of stock options to purchase the Issuer's common stock. See Footnote 4 below for further details on the relevant stock options.
[F4]Represents previously reported ten year non-qualified stock options to purchase 5,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options vested on September 1, 2013.
[F5]Represents previously reported stock options to purchase 20,000 shares of the Issuer's common stock, granted pursuant to a stock option agreement dated April 20, 2012. The options vested in two equal tranches on October 21, 2012 and April 21, 2013.
[F6]Includes the balance of the previously reported stock options as disclosed in Footnotes 4 and 5 above.

Documents

1 file

4
v426478_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

China Biologic Products, Inc.

CIK 0001369868

→

Entity typeoperating

Related Parties

filerCIK 0001369868

Filing Metadata

Form type: 4
Filed: Dec 7, 7:00 PM ET
Accepted: Dec 8, 4:35 PM ET
Size: 21.1 KB

View on SEC.gov